O-GlcNAc modification of transcription factors, glucose sensing and glucotoxicity

Trends in Endocrinology and Metabolism

Volumn 19, Issue 10, 2008, Pages 380-389

  Issad, Tarik ^a,b   Kuo, MeiShiue ^a,b  

^a INSTITUT COCHIN   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEPTIN; N ACETYLGLUCOSAMINE; NEUROGENIC DIFFERENTIATION FACTOR; PROTEIN P53; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR PDX 1; TRANSCRIPTION FACTOR SP1;

ADIPOSE TISSUE; DIABETES MELLITUS; GLUCONEOGENESIS; GLUCOSE INTOLERANCE; HUMAN; HYPERGLYCEMIA; INSULIN SYNTHESIS; NONHUMAN; NUTRIENT AVAILABILITY; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW;

ACETYLGLUCOSAMINE; ANIMALS; GLUCOSE; HUMANS; MODELS, BIOLOGICAL; PROTEIN PROCESSING, POST-TRANSLATIONAL; TRANSCRIPTION FACTORS;

EID: 55649110871     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2008.09.001     Document Type: Review

References (70)

1. Hart G.W., et al. Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 446 (2007) 1017-1022
2. Yang X., et al. Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance. Nature 451 (2008) 964-969
3. Kuo M., et al. O-glycosylation of FoxO1 increases its transcriptional activity towards the glucose 6-phosphatase gene. FEBS Lett. 582 (2008) 829-834
4. Kuo M., et al. O-GlcNAc modification of FoxO1 increases its transcriptional activity: a role in the glucotoxicity phenomenon?. Biochimie 90 (2008) 679-685
5. Housley M.P., et al. O-GlcNAc regulates FoxO activation in response to glucose. J. Biol. Chem. 283 (2008) 16283-16292
6. Dentin R., et al. Hepatic glucose sensing via the CREB coactivator CRTC2. Science 319 (2008) 1402-1405
7. Zachara N.E., and Hart G.W. O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress. Biochim. Biophys. Acta 1673 (2004) 13-28
8. Love D.C., and Hanover J.A. The hexosamine signaling pathway: deciphering the "O-GlcNAc code". Sci. STKE 2005 (2005) re13
9. Zachara N.E., and Hart G.W. Cell signaling, the essential role of O-GlcNAc! Biochim. Biophys. Acta 1761 (2006) 599-617
10. Obici S., and Rossetti L. Minireview: nutrient sensing and the regulation of insulin action and energy balance. Endocrinology 144 (2003) 5172-5178
11. Marshall S. Role of insulin, adipocyte hormones, and nutrient-sensing pathways in regulating fuel metabolism and energy homeostasis: a nutritional perspective of diabetes, obesity, and cancer. Sci. STKE 2006 (2006) re7
12. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54 (2005) 1615-1625
13. Cerf M.E. Transcription factors regulating β-cell function. Eur. J. Endocrinol. 155 (2006) 671-679
14. Babu D.A., et al. A feat of metabolic proportions: Pdx1 orchestrates islet development and function in the maintenance of glucose homeostasis. Mol. Genet. Metab. 92 (2007) 43-55
15. Gao Y., et al. The transcription factor PDX-1 is post-translationally modified by O-linked N-acetylglucosamine and this modification is correlated with its DNA binding activity and insulin secretion in min6 β-cells. Arch. Biochem. Biophys. 415 (2003) 155-163
16. Akimoto Y., et al. Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats. Glycobiology 17 (2007) 127-140
17. Chae J.H., et al. NeuroD: the predicted and the surprising. Mol. Cells 18 (2004) 271-288
18. Petersen H.V., et al. Glucose induced MAPK signalling influences NeuroD1-mediated activation and nuclear localization. FEBS Lett. 528 (2002) 241-245
19. Andrali S.S., et al. Glucose mediates the translocation of NeuroD1 by O-linked glycosylation. J. Biol. Chem. 282 (2007) 15589-15596
20. Li L., et al. Gene regulation by Sp1 and Sp3. Biochem. Cell Biol. 82 (2004) 460-471
21. Wierstra I. Sp1: emerging roles-beyond constitutive activation of TATA-less housekeeping genes. Biochem. Biophys. Res. Commun. 372 (2008) 1-13
22. Kudlow J.E. Post-translational modification by O-GlcNAc: another way to change protein function. J. Cell. Biochem. 98 (2006) 1062-1075
23. Goldberg H.J., et al. Posttranslational, reversible O-glycosylation is stimulated by high glucose and mediates plasminogen activator inhibitor-1 gene expression and Sp1 transcriptional activity in glomerular mesangial cells. Endocrinology 147 (2006) 222-231
24. Chung S.S., et al. Activation of PPARγ negatively regulates O-GlcNAcylation of Sp1. Biochem. Biophys. Res. Commun. 372 (2008) 713-718
25. Majumdar G., et al. Insulin dynamically regulates calmodulin gene expression by sequential O-glycosylation and phosphorylation of Sp1 and its subcellular compartmentalization in liver cells. J. Biol. Chem. 281 (2006) 3642-3650
26. Moreno-Aliaga M.J., et al. Sp1-mediated transcription is involved in the induction of leptin by insulin-stimulated glucose metabolism. J. Mol. Endocrinol. 38 (2007) 537-546
27. Zhang P., et al. Hexosamines regulate leptin production in 3T3-L1 adipocytes through transcriptional mechanisms. Endocrinology 143 (2002) 99-106
28. Einstein F.H., et al. Differential responses of visceral and subcutaneous fat depots to nutrients. Diabetes 54 (2005) 672-678
29. Buse M.G. Hexosamines, insulin resistance, and the complications of diabetes: current status. Am. J. Physiol. Endocrinol. Metab. 290 (2006) E1-E8
30. Kusminski C.M., et al. Role of resistin in obesity, insulin resistance and Type II diabetes. Clin. Sci. (Lond.) 109 (2005) 243-256
31. Smith S.R., et al. A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes 52 (2003) 1611-1618
32. Osawa H., et al. The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3. Am. J. Hum. Genet. 75 (2004) 678-686
33. Chung S.S., et al. Regulation of human resistin gene expression in cell systems: an important role of stimulatory protein 1 interaction with a common promoter polymorphic site. Diabetologia 48 (2005) 1150-1158
34. Chung S.S., et al. Sp1 mediates repression of the resistin gene by PPARγ agonists in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 348 (2006) 253-258
35. Fulop N., et al. Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system. Cardiovasc. Res. 73 (2007) 288-297
36. Du X.L., et al. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 12222-12226
37. Schrijvers B.F., and De Vriese A.S. Novel insights in the treatment of diabetic nephropathy. Acta Clin. Belg. 62 (2007) 278-290
38. Masson E., et al. Hyperglycemia and glucosamine-induced mesangial cell cycle arrest and hypertrophy: Common or independent mechanisms?. IUBMB Life 58 (2006) 381-388
39. Karin M. Inflammation-activated protein kinases as targets for drug development. Proc. Am. Thorac. Soc. 2 (2005) 386-390
40. Sonnenberg G.E., et al. A novel pathway to the manifestations of metabolic syndrome. Obes. Res. 12 (2004) 180-186
41. Dandona P., et al. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111 (2005) 1448-1454
42. Schmid H., et al. Modular activation of nuclear factor-κB transcriptional programs in human diabetic nephropathy. Diabetes 55 (2006) 2993-3003
43. James L.R., et al. Flux through the hexosamine pathway is a determinant of nuclear factor κB- dependent promoter activation. Diabetes 51 (2002) 1146-1156
44. Golks A., et al. Requirement for O-linked N-acetylglucosaminyltransferase in lymphocytes activation. EMBO J. 26 (2007) 4368-4379
45. Millau J.F., et al. P53 transcriptional activities: a general overview and some thoughts. Mutat. Res. (2008) 10.1016/J.mrrev.2008.06.002
46. Yang W.H., et al. Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. Nat. Cell Biol. 8 (2006) 1074-1083
47. Fiordaliso F., et al. Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes 50 (2001) 2363-2375
48. Barthel A., et al. FoxO proteins in insulin action and metabolism. Trends Endocrinol. Metab. 16 (2005) 183-189
49. D'Alessandris C., et al. Increased O-glycosylation of insulin signaling proteins results in their impaired activation and enhanced susceptibility to apoptosis in pancreatic beta-cells. FASEB J. 18 (2004) 959-961
50. Robertson R.P., and Harmon J.S. Diabetes, glucose toxicity, and oxidative stress: a case of double jeopardy for the pancreatic islet beta cell. Free Radic. Biol. Med. 41 (2006) 177-184
51. Glauser D.A., and Schlegel W. The emerging role of FOXO transcription factors in pancreatic β cells. J. Endocrinol. 193 (2007) 195-207
52. Rask-Madsen C., and King G.L. More sugar, less blood vessels. Another piece in the puzzle of increased cardiovasuclar risk in diabetes. Arterioscler. Thromb. Vasc. Biol. 28 (2008) 608-610
53. Musicki B., et al. Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 11870-11875
54. Luo B., et al. Protein modification by O-linked GlcNAc reduces angiogenesis by inhibiting Akt activity in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 28 (2008) 651-657
55. Paik J.H. FOXOs in the maintenance of vascular homoeostasis. Biochem. Soc. Trans. 34 (2006) 731-734
56. Guinez C., et al. O-GlcNAc glycosylation: a signal for the nuclear transport of cytosolic proteins?. Int. J. Biochem. Cell Biol. 37 (2005) 765-774
57. Gewinner C., et al. The coactivator of transcription CREB-binding protein interacts preferentially with the glycosylated form of Stat5. J. Biol. Chem. 279 (2004) 3563-3572
58. Khidekel N., et al. Exploring the O-GlcNAc proteome: direct identification of O-GlcNAc-modified proteins from the brain. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 13132-13137
59. Vosseller K., et al. O-linked N-acetylglucosamine proteomics of postsynaptic density preparations using lectin weak affinity chromatography and mass spectrometry. Mol. Cell. Proteomics 5 (2006) 923-934
60. Khidekel N., et al. Probing the dynamics of O-GlcNAc glycosylation in the brain using quantitative proteomics. Nat. Chem. Biol. 3 (2007) 339-348
61. Rossetti L. Perspective: Hexosamines and nutrient sensing. Endocrinology 141 (2000) 1922-1925
62. McClain D.A. Hexosamines as mediators of nutrient sensing and regulation in diabetes. J. Diabetes Complications 16 (2002) 72-80
63. Hazel M., et al. Activation of the hexosamine signaling pathway in adipose tissue results in decreased serum adiponectin and skeletal muscle insulin resistance. Endocrinology 145 (2004) 2118-2128
64. Towle H.C. Glucose as a regulator of eukaryotic gene transcription. Trends Endocrinol. Metab. 16 (2005) 489-494
65. Zraika S., et al. The hexosamine biosynthesis pathway regulates insulin secretion via protein glycosylation in mouse islets. Arch. Biochem. Biophys. 405 (2002) 275-279
66. Cooksey R.C., et al. Hexosamines regulate sensitivity of glucose-stimulated insulin secretion in β-cells. Am. J. Physiol. Endocrinol. Metab. 290 (2006) E334-E340
67. Hanover J.A. Glycan-dependent signaling: O-linked N-acetylglucosamine. FASEB J. 15 (2001) 1865-1876
68. Liu K., et al. Glucose stimulates protein modification by O-linked GlcNAc in pancreatic β cells: linkage of O-linked GlcNAc to β cell death. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 2820-2825
69. Babu D.A., et al. Pdx1 and BETA2/NeuroD1 participate in a transcriptional complex that mediates short-range DNA looping at the insulin gene. J. Biol. Chem. 283 (2008) 8164-8172
70. Allen D.A., et al. Mechanisms of high glucose-induced apoptosis and its relationship to diabetic complications. J. Nutr. Biochem. 16 (2005) 705-713